178 studies found for:    breast,cancer,prevention | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
Condition: Advanced Breast Cancer
Intervention: Drug: Dexamethasone based mouth
22 Recruiting Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin
Conditions: Breast Cancer;   Stage I Breast Cancer;   Stage II Breast Cancer;   Stage III Breast Cancer
Interventions: Drug: Simvastatin;   Drug: Doxorubicin/cyclophosphamide
23 Unknown  Statins and Breast Cancer Biomarkers
Condition: Breast Cancer
Interventions: Drug: Atorvastatin;   Drug: Placebo
24 Recruiting Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer
Conditions: Atypical Ductal Breast Hyperplasia;   BRCA1 Gene Mutation;   BRCA2 Gene Mutation;   Ductal Breast Carcinoma in Situ;   Lobular Breast Carcinoma in Situ
Interventions: Dietary Supplement: curcumin;   Other: Biomarker analysis;   Other: Assessment of Dietary Intake;   Other: Daily Log
25 Recruiting Carvedilol for the Prevention of Anthracycline/Anti-HER2 Therapy Associated Cardiotoxicity Among Women With HER2-Positive Breast Cancer Using Myocardial Strain Imaging for Early Risk Stratification
Condition: Breast Cancer
Interventions: Drug: Carvedilol;   Other: placebo
26 Unknown  Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor
Conditions: Febrile Neutropenia;   Cancer;   Breast Cancer;   Ovarian Cancer;   Lung Cancer;   Prostate Cancer;   Multiple Myeloma;   Bladder Cancer;   B-cell Lymphoma
Intervention:
27 Recruiting My Lifestyle Intervention of Food and Exercise
Condition: Breast Cancer
Interventions: Behavioral: Tailored Lifestyle Intervention (TLI);   Behavioral: Commercial Weight Loss Program (CWLP)
28 Unknown  Pasireotide LAR Administration in Lymphocele Prevention After Axillary Node Dissection for Breast Cancer
Condition: Breast Cancer
Interventions: Drug: PASIREOTIDE;   Drug: PLACEBO
29 Not yet recruiting Exercise to Prevent Aromatase Inhibitor Side Effects in Breast Cancer Patients
Conditions: Breast Cancer;   Sarcopenia
Interventions: Other: Structured Exercise;   Other: Usual Care
30 Recruiting Prophylactic Irradiation to the Contralateral Breast for BRCA Mutation Carriers Undergoing Treatment for Breast Cancer
Condition: Breast Cancer
Intervention: Radiation: Prophylactic radiation to the contralateral breast
31 Recruiting Laser InGaAlP (660Nm) to Prevent Radiodermatitis in Breast Cancer Patients Submitted to Radiation Therapy
Conditions: Radiotherapy; Adverse Effect, Dermatitis or Eczema;   Breast Neoplasms
Interventions: Device: Laser therapy;   Device: Placebo
32 Unknown  Use of Organic Germanium or Placebo for the Prevention of Radiation Induced Fatigue
Conditions: Localized Breast Cancer;   Localized Prostate Cancer;   Patients Receiving External Beam Radiotherapy
Interventions: Dietary Supplement: Organic Germanium;   Dietary Supplement: Placebo
33 Recruiting Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life
Condition: Breast Cancer
Intervention: Behavioral: survey web-based or telephone interview
34 Unknown  Breast Cancer and Exercise Trial in Alberta
Condition: Breast Neoplasms
Interventions: Other: Volume of Exercise; Moderate or High Volume;   Other: Aerobic Exercise
35 Unknown  Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity
Condition: Breast Cancer
Interventions: Drug: AT1 blocker candesartan;   Drug: Placebo
36 Unknown  Study of Neoadjuvant Docetaxel and Cyclophosphamide in Locally Advanced or Node Positive Primary Breast Cancer With Companion Pharmacokinetic and Pharmacogenomic Analyses
Condition: Breast Cancer
Intervention: Drug: Neoadjuvant Docetaxel and Cyclophosphamide
37 Recruiting Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
Conditions: Familial Ovarian Cancer;   Familial Breast Cancer;   BRCA1-associate Malignancies;   BRCA2-associated Malignancies
Intervention:
38 Recruiting Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer;   HER2-positive Breast Cancer;   Progesterone Receptor-positive Breast Cancer;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Drug: docetaxel;   Drug: carboplatin;   Biological: trastuzumab;   Biological: pertuzumab;   Drug: goserelin acetate;   Procedure: therapeutic conventional surgery;   Radiation: whole breast irradiation;   Other: laboratory biomarker analysis;   Drug: aromatase inhibition therapy;   Other: quality-of-life assessment
39 Recruiting Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection
Conditions: Breast Cancer;   Lymphedema;   Perioperative/Postoperative Complications
Interventions: Behavioral: exercise intervention;   Other: educational intervention;   Procedure: assessment of therapy complications;   Procedure: complementary or alternative medicine procedure;   Procedure: management of therapy complications;   Procedure: quality-of-life assessment;   Procedure: therapeutic conventional surgery
40 Recruiting Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence
Condition: HER2 Low to Intermediate Breast Cancer
Interventions: Biological: NeuVax™ vaccine;   Biological: Leukine® (sargramostim, GM-CSF) and water for injection

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years